1. Announcement Express

China Merchants Shekou: In the first three quarters, the cumulative contracted sales amount was about 145.2 billion yuan, and 3 new residential land projects were added

On October 9, China Merchants Shekou (001979. SZ) announced that in September 2024, the company achieved a contracted sales area of 694,800 square meters and a contracted sales amount of 14.358 billion yuan. From January to September 2024, the company has achieved a cumulative contracted sales area of 6,424,400 square meters and a cumulative contracted sales amount of 145.171 billion yuan.

In addition, the company has recently added three new projects, which are located in Jing'an District, Shanghai, Nansha District, Guangzhou City and Xi'an Port District, all of which are residential.

Hytera: 10 days and 9 boards, the final result of the lawsuit may have a certain impact on the company's profits

On October 9, Hytera (002583. SZ) issued a change announcement, the company's shares for two consecutive trading days closing price increase deviation of more than 20%, belongs to the abnormal fluctuation of stock trading. After verification, the company's current business situation is normal, and there have been no major changes in the internal and external business environment. The United States Court of Appeals for the Seventh Circuit denied the motion filed by the Company for reconsideration and re-judgment in the trade secret and copyright infringement lawsuit between the Company and MOTOROLA SOLUTIONS INC. and Motorola Malaysia. The final outcome of the lawsuit may have an impact on the company's profits

Dongpeng Beverage: Net profit in the first three quarters is expected to increase by 57.04% to 64.89%.

On October 9, Dongpeng Beverage (605499. SH) announced that its performance is expected to increase in the first three quarters of 2024. The company expects to achieve revenue of 12.4 billion yuan to 12.72 billion yuan in the first three quarters, a year-on-year increase of 43.50% to 47.21%; It is expected to achieve net profit attributable to the parent company

between 2.6 billion yuan and 2.73 billion yuan, a year-on-year increase of 57.04% to 64.89%; It is estimated that the net profit deducted from non-attributable to the parent company will be 2.55 billion yuan to 2.68 billion yuan, a year-on-year increase of 69.76% to 78.41%.

EVE: Received a fixed-point letter from a European group for FCEV projects

On October 9, EVE (300014. SZ) announced that the company received a designated letter from a European group, and the company was nominated by a European group as a cooperative supplier for the development of the FueI Cell Electric Vehicle (hereinafter referred to as "FCEV") project.

Anel: Zhang Xi resigned as the company's general manager and chief executive officer

On October 9, SZ 002875 announced that Ms. Zhang Xi resigned as the company's general manager and CEO due to job changes. After her resignation, Ms. Zhang Xi will no longer hold any position in the Company.

Gemdale Group: In September, the contract amount reached 5.2 billion yuan

On October 9, Gemdale Group (600383. SH) announced that in September 2024, the company achieved a contracted area of 377,000 square meters, a year-on-year decrease of 45.02%; The contracted amount was 5.2 billion yuan, a year-on-year decrease of 60.33%. From January to September 2024, the company achieved a cumulative contracted area of 3.593 million square meters, a year-on-year decrease of 46.29%; The cumulative contracted amount was 52.81 billion yuan, a year-on-year decrease of 56.69%.

Jin Xinnong: The sales revenue of live pigs in September was 151 million yuan

On October 9, Jin Xinnong (002548. SZ) announced that the company's live pig sales in September 2024 were 93,900 (including 56,400 commercial pigs, 33,300 piglets, and 4,200 breeding pigs), with a sales revenue of 1.505 billion yuan and an average sales price of 18.95 yuan/kg.

Second, the front line of innovation

Kangtai Biotech: Quadrivalent influenza virus split vaccine was approved for clinical trials

On October 9, Kangtai Biotechnology (300601. SZ) announced in the evening that the quadrivalent influenza virus split vaccine (MDCK cell) developed by the company and Lanzhou Bailing Biotechnology Co., Ltd. recently obtained the "Drug Clinical Trial Approval Notice" issued by the State Drug Administration. The vaccine is suitable for people aged 3 years and above and stimulates the body to develop immunity against influenza viruses and is used to prevent influenza caused by vaccine-related influenza viruses.

3. Capital navigation

BIWIN Storage: The company's private placement was accepted by the Shanghai Stock Exchange

On October 9th, BIWIN Storage (688525. SH) announced that the company received the "Notice on Accepting the Application for Issuance of Securities by Listed Companies on the Science and Technology Innovation Board of Shenzhen BIWIN Storage Technology Co., Ltd." issued by the Shanghai Stock Exchange. In accordance with relevant regulations, the SSE shall accept the prospectus and related application documents submitted by the company and review them in accordance with the law.

German Nano: A total of 105 million yuan has been used to repurchase about 2.81 million shares

On October 9, German Nano (SZ 300769) announced that as of September 30, 2024, the company has repurchased about 2.81 million shares of the company through the Shenzhen Stock Exchange trading system through centralized bidding transactions, accounting for 1% of the company's current total share capital, with the highest transaction price of 60.2 yuan / share and the lowest transaction price of 25.96 yuan / share, with a total transaction amount of about 105 million yuan.

Kuang-Chi Technology: Semi-annual equity distribution of 2.33 yuan per 10 shares

On October 9th, Kuang-Chi Technology (002625. SZ) announced that the company's 2024 semi-annual equity distribution plan is based on the company's existing total share capital after deducting the total share capital that has been repurchased on the company's special securities account for repurchased shares, and a cash dividend of RMB 2.33 (tax included) will be distributed to all shareholders for every 10 shares.

Demingli: On October 14, 440,500 shares were lifted, involving 89 incentive recipients

On October 9, Demingli (001309. SZ) announced that the restricted stock incentive plan in 2023 will grant restricted shares for the first time, and the restricted shares will be released for listing and circulation during the first release period. The lifting of restricted shares involves 89 incentive recipients, and the total number of restricted shares released is 440476 shares, accounting for 0.2985% of the company's current total share capital, and the listing and circulation date is October 14, 2024.